During the past decade, People's Hospital of Wuhan University conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "People's Hospital of Wuhan University" #1 sponsor was "Renmin Hospital of Wuhan University" with 3 trials, followed by "Lifetech Scientific (Shenzhen) Co., Ltd." with 2 trials sponsored, "Takeda" with 2 trials sponsored, "Beijing Tiantan Hospital" with 1 trials sponsored and "Chengdu Kanghong Biotech Co., Ltd." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "People's Hospital of Wuhan University" #1 collaborator was "Ministry of Science and Technology of the People's Republic of China" with 1 trials as a collaborator, "Nanjing Medical University" with 1 trials as a collaborator and "University of Wisconsin, Madison" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "People's Hospital of Wuhan University" are "Atrial Fibrillation" (2 trials), "Acute Stroke" (1 trials), "Chronic Constipation" (1 trials), "Colorectal Cancer" (1 trials) and "Community-acquired Pneumonia" (1 trials). Many other conditions were trialed in "People's Hospital of Wuhan University" in a lesser frequency.

Most popular intervention types in "People's Hospital of Wuhan University" are "Drug" (6 trials), "Device" (2 trials), "Biological" (1 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adefovir" (1 trials), "Amlodipine" (1 trials), "Amlodipine Placebo" (1 trials), "Delayed high-intensity statin" (1 trials) and "Dragonfly Opstar Imaging Catheter" (1 trials). Other intervention names were less common.

The vast majority of trials in "People's Hospital of Wuhan University" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "People's Hospital of Wuhan University". 1 are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in People's Hospital of Wuhan University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in People's Hospital of Wuhan University, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".